Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) antibody
| Antigen | Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) |
| Synonyms | PGDH, PGDH1, 15-PGDH, SDR36C1, MGC80546, MGC79454, MGC127443, HPGD, DKFZp469E0623, AV026552, MGC14001 |
| Clonality | Polyclonal |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB) |
![]() |
4 references available |
| Catalog no. | ABIN268223 |
| Quantity | 25 µl (2.0 mg/ml) (Variants) |
| Price | Product not available in this region. |
| Shipping to |
|
Additional Information
| Alternative name | HPGD |
| Gene ID | 3248 |
| Immunogen | Purified type I human placental 15-PGDH protein. |
| Cross-Reactivity | Human |
| Description | 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a novel tumor suppressor in theCOX-2 pathway. The protein is found in many normal tissues and appears to bedown-regulated in colorectal and lung carcinoma tissue. Alternate Names: anti-15-hydroxyprostaglandin dehydrogenase [NAD+] antibody, anti-Prostaglandindehydrogenase 1 antibody, anti-HPGD antibody, anti-PGDH1 antibody. |
| Specificity | This antibody is specific for 15-PGDH. Species Reactivity: This antibody reacts with human 15-PGDH protein. No other species have been tested. Localization: Cytoplasmic. |
Application Details
| Application Notes | Positive Controls: Treated A549 lung carcinoma cell lysates (see note) and LoVo colon carcinoma celllysates. |
| Concentration | 2.0 mg/ml |
| Purification | Purified |
| Buffer | Tris-glycine, 150mM NaCl. Preservative: 0.05% sodium azide. |
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze thaw cycles. |
| Restrictions | For Research Use only |
Publications
|
Giannoulias, Patel, Holloway et al.: "Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium." in: The Journal of clinical endocrinology and metabolism, Vol. 87, Issue 3, pp. 1345-52, 2002 (PubMed).
Ding, Tong, Liu et al.: "NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer." in: Carcinogenesis, Vol. 26, Issue 1, pp. 65-72, 2004 (PubMed). Backlund, Mann, Holla et al.: "Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer." in: Cancer research, Vol. 68, Issue 22, pp. 9331-7, 2008 (PubMed). Hughes, Otani, Yang et al.: "NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer." in: Cancer prevention research (Philadelphia, Pa.), Vol. 1, Issue 4, pp. 241-9, 2009 (PubMed). |
|
Alternatives
Alternatives for antigen "Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD)", type "Antibodies"
| Hosts | Rabbit (34), Goat (6), Mouse (6) |
| Reactivities | Human (45), Mouse (Murine) (22), Rat (Rattus) (22), Cow (Bovine) (19), Horse (Equine) (18), Pig (Porcine) (18), Cat (Feline) (1), Chicken (1), Dog (Canine) (1), Monkey (1) |
| Applications | Western Blotting (WB) (29), Immunofluorescence (IF) (19), ELISA (16), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (10), Immunohistochemistry (IHC) (9), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) (3), Immunoprecipitation (IP) (3), Flow Cytometry (FACS) (2), Immunocytochemistry (ICC) (1), Immunoelectron Microscopy (IEM) (1) |
| Conjugates | Biotin (2), HRP (2), Alexa Fluor 350 (1), Alexa Fluor 488 (1), Alexa Fluor 555 (1), Alexa Fluor 647 (1), Cy3 (1), Cy5 (1), Cy5.5 (1), Cy7 (1), FITC (1), Gold (1), PE (1), PE,Cy3 (1), PE,Cy5 (1), PE,Cy5.5 (1), PE,Cy7 (1) |
| Epitopes | C-Term (2), N-Term (2), AA 1-266 (1) |




Alternatives